143 related articles for article (PubMed ID: 27717886)
1. The interplay between intracellular progesterone receptor and PKC plays a key role in migration and invasion of human glioblastoma cells.
Marquina-Sánchez B; González-Jorge J; Hansberg-Pastor V; Wegman-Ostrosky T; Baranda-Ávila N; Mejía-Pérez S; Camacho-Arroyo I; González-Arenas A
J Steroid Biochem Mol Biol; 2017 Sep; 172():198-206. PubMed ID: 27717886
[TBL] [Abstract][Full Text] [Related]
2. PKCα and PKCδ activation regulates transcriptional activity and degradation of progesterone receptor in human astrocytoma cells.
González-Arenas A; Peña-Ortiz MÁ; Hansberg-Pastor V; Marquina-Sánchez B; Baranda-Ávila N; Nava-Castro K; Cabrera-Wrooman A; González-Jorge J; Camacho-Arroyo I
Endocrinology; 2015 Mar; 156(3):1010-22. PubMed ID: 25514083
[TBL] [Abstract][Full Text] [Related]
3. Proliferative and Invasive Effects of Progesterone-Induced Blocking Factor in Human Glioblastoma Cells.
Gutiérrez-Rodríguez A; Hansberg-Pastor V; Camacho-Arroyo I
Biomed Res Int; 2017; 2017():1295087. PubMed ID: 28168193
[TBL] [Abstract][Full Text] [Related]
4. Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway.
González-Arenas A; Valadez-Cosmes P; Jiménez-Arellano C; López-Sánchez M; Camacho-Arroyo I
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():463-70. PubMed ID: 25218441
[TBL] [Abstract][Full Text] [Related]
5. LPA
Valdés-Rives SA; Arcos-Montoya D; de la Fuente-Granada M; Zamora-Sánchez CJ; Arias-Romero LE; Villamar-Cruz O; Camacho-Arroyo I; Pérez-Tapia SM; González-Arenas A
Cells; 2021 Apr; 10(4):. PubMed ID: 33916643
[TBL] [Abstract][Full Text] [Related]
6. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.
Srivastava MD; Thomas A; Srivastava BI; Check JH
Leuk Lymphoma; 2007 Aug; 48(8):1610-7. PubMed ID: 17701593
[TBL] [Abstract][Full Text] [Related]
7. 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression.
Lin CW; Shen SC; Chien CC; Yang LY; Shia LT; Chen YC
J Cell Physiol; 2010 Nov; 225(2):472-81. PubMed ID: 20458747
[TBL] [Abstract][Full Text] [Related]
8. Activation of membrane progesterone receptor-alpha increases proliferation, migration, and invasion of human glioblastoma cells.
González-Orozco JC; Hansberg-Pastor V; Valadez-Cosmes P; Nicolas-Ortega W; Bastida-Beristain Y; Fuente-Granada M; González-Arenas A; Camacho-Arroyo I
Mol Cell Endocrinol; 2018 Dec; 477():81-89. PubMed ID: 29894708
[TBL] [Abstract][Full Text] [Related]
9. Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells.
Bello-Alvarez C; Moral-Morales AD; González-Arenas A; Camacho-Arroyo I
Front Endocrinol (Lausanne); 2021; 12():640298. PubMed ID: 33841333
[TBL] [Abstract][Full Text] [Related]
10. Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells.
Piña-Medina AG; Hansberg-Pastor V; González-Arenas A; Cerbón M; Camacho-Arroyo I
Steroids; 2016 Jan; 105():19-25. PubMed ID: 26639431
[TBL] [Abstract][Full Text] [Related]
11. PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.
Lachmann M; Gelbmann D; Kálmán E; Polgár B; Buschle M; Von Gabain A; Szekeres-Barthó J; Nagy E
Int J Cancer; 2004 Oct; 112(1):51-60. PubMed ID: 15305375
[TBL] [Abstract][Full Text] [Related]
12. A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
Check JH; Check DL
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830233
[TBL] [Abstract][Full Text] [Related]
13. The effect of the Progesterone-Induced Blocking Factor (PIBF) on E-cadherin expression, cell motility and invasion of primary tumour cell lines.
Balassa T; Berta G; Jakab L; Bohonyi N; Szekeres-Bartho J
J Reprod Immunol; 2018 Feb; 125():8-15. PubMed ID: 29107859
[TBL] [Abstract][Full Text] [Related]
14. Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity.
Check JH; Sansoucie L; Chern J; Amadi N; Srivastava M; Larece K
Clin Exp Obstet Gynecol; 2007; 34(4):207-11. PubMed ID: 18225679
[TBL] [Abstract][Full Text] [Related]
15. Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 breast adenocarcinoma cells invasion/migration by α-tomatine through activating PKCα/ERK/NF-κB-dependent MMP-2/MMP-9 expressions.
Shi MD; Shih YW; Lee YS; Cheng YF; Tsai LY
Cell Biochem Biophys; 2013 May; 66(1):161-74. PubMed ID: 23114726
[TBL] [Abstract][Full Text] [Related]
16. The role of PKC isoforms in the inhibition of NF-κB activation by vitamin K2 in human hepatocellular carcinoma cells.
Xia J; Matsuhashi S; Hamajima H; Iwane S; Takahashi H; Eguchi Y; Mizuta T; Fujimoto K; Kuroda S; Ozaki I
J Nutr Biochem; 2012 Dec; 23(12):1668-75. PubMed ID: 22475810
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation.
Kazmi SM; Visconti V; Plante RK; Ishaque A; Lau C
Endocrinology; 1993 Sep; 133(3):1230-8. PubMed ID: 8365365
[TBL] [Abstract][Full Text] [Related]
18. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
Han SJ; Tsai SY; Tsai MJ; O'Malley BW
Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
[TBL] [Abstract][Full Text] [Related]
19. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation.
Chiu WT; Shen SC; Chow JM; Lin CW; Shia LT; Chen YC
Neurobiol Dis; 2010 Jan; 37(1):118-29. PubMed ID: 19804834
[TBL] [Abstract][Full Text] [Related]
20. Modulators of cellular protein phosphorylation alter the trans-activation function of human progesterone receptor and the biological activity of progesterone antagonists.
Edwards DP; Weigel NL; Nordeen SK; Beck CA
Breast Cancer Res Treat; 1993; 27(1-2):41-56. PubMed ID: 8260729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
